Unicycive Therapeutics In...
(UNCY)
undefined
undefined%
At close: undefined
0.72
0.81%
Pre-market Dec 16, 2024, 04:28 AM EST
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts,
total investments, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
Cash & Equivalents | 9.70M | 455.00K | 16.58M | - | 15.00K | 25.00K |
Short-Term Investments | - | - | - | - | - | - |
Long-Term Investments | - | - | - | - | - | - |
Other Long-Term Assets | - | -174.00K | -333.00K | 200.00K | - | - |
Receivables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other Current Assets | 3.70M | 2.19M | 1.83M | 204.00K | 4.00K | 4.00K |
Total Current Assets | 13.40M | 2.64M | 18.41M | 204.00K | 19.00K | 29.00K |
Property-Plant & Equipment | 792.00K | 174.00K | 333.00K | - | - | - |
Goodwill & Intangibles | - | - | - | - | - | - |
Total Long-Term Assets | 792.00K | 174.00K | 333.00K | 200.00K | - | - |
Total Assets | 14.19M | 2.82M | 18.74M | 204.00K | 19.00K | 29.00K |
Account Payables | 821.00K | 846.00K | 713.00K | 184.00K | 322.00K | 60.00K |
Deferred Revenue | -18.00K | - | - | - | - | 1.00 |
Short-Term Debt | 345.00K | 310.00K | 302.00K | 2.51M | 460.00K | 1.05M |
Other Current Liabilities | 16.37M | 2.13M | 1.09M | 177.00K | 121.00K | 128.00K |
Total Current Liabilities | 17.53M | 3.28M | 2.10M | 2.88M | 903.00K | 1.24M |
Long-Term Debt | 466.00K | - | 155.00K | - | - | - |
Other Long-Term Liabilities | - | - | - | - | - | - |
Total Long-Term Liabilities | 466.00K | 1.05K | 155.00K | - | - | - |
Total Liabilities | 18.00M | 3.28M | 2.26M | 2.88M | 903.00K | 1.24M |
Total Debt | 811.00K | 155.00K | 306.00K | 2.51M | 460.00K | 1.05M |
Common Stock | 35.00K | 15.00K | 15.00K | 9.00K | 8.00K | 34.00K |
Retained Earnings | -64.54M | -34.00M | -15.94M | -5.92M | -3.66M | -1.49M |
Comprehensive Income | - | - | - | - | - | 0.00 |
Shareholders Equity | -3.81M | -466.00K | 16.48M | -2.67M | -884.00K | -1.21M |
Total Investments | - | - | - | - | - | - |